In 2023, the global preclinical imaging market was valued at US$ 3.8 billion. IMARC Group forecasts the market to grow to US$ 5.0 billion by 2032, with a compound annual growth rate (CAGR) of 2.97% from 2024 to 2032. Preclinical imaging plays a critical role in drug development and biomedical research, enabling non-invasive visualization of biological processes in animal models. The m... https://www.imarcgroup.com/preclinical-imaging-market